Impact of baicalin and components of Scutellaria baicalensis on renal fibrosis of diabetic kidney disease

被引:0
作者
Li, Jiarui [1 ,2 ]
Zhuang, Yuan [1 ,2 ]
Fan, Guoyong [1 ,3 ]
Wang, Simeng [1 ]
Yan, Enhui [1 ,3 ]
Guo, Jianpeng [2 ]
Zhang, Chi [1 ,3 ]
Jiang, Shicui [1 ,2 ,3 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 3, Ruian Peoples Hosp, Wenzhou Key Lab Diag & Prevent Diabetic Complicat, Ruian, Peoples R China
[2] Yanbian Univ, Coll Pharm, Yanji, Jilin, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 3, Ruian Peoples Hosp, Liji Med Res Acad, Ruian, Peoples R China
基金
美国国家科学基金会;
关键词
flavonoids; traditional Chinese medicine; diabetic nephropathy; baicalin; renal fibrosis; insulin sensitivity; OXIDATIVE STRESS; TGF-BETA; NEPHROPATHY; INJURY; RATS; MICE;
D O I
10.3389/fphar.2024.1480626
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Fibrosis is key in the development and progression of diabetic kidney disease (DKD). Baicalin (BA), wogonin (WGN), and wogonoside (WGS) have renoprotective effects. The mechanism of alleviation of DKD progression, by improving renal fibrosis, is unclear. This study aimed to investigate the mechanisms and effects of a Scutellaria baicalensis Georgi. (Lamiaceae) mixture (MIX, WGN:BA:WGS = 4:2:1) on DKD in a spontaneous DKD model.Methods Male db/m mice were controls, and db/db mice were diabetes models. Both groups received daily oral gavage of normal saline. Treatment groups received daily oral gavage of BA or MIX (20 mg/kg) for 10 weeks. Biochemical indicators and kidney lesions were assessed. Fibrosis-related proteins were detected by immunoblotting, immunohistochemistry, and real-time fluorescence quantitative PCR.Results MIX significantly reduced body weight (40.97 +/- 1.43 vs. 42.26 +/- 1.60), improved insulin sensitivity (63.70 +/- 8.98 vs. 109.48 +/- 0.69), lowered the renal hypertrophy index (19.81 +/- 2.86 vs. 28.94 +/- 0.256), and decreased blood urea nitrogen levels (7.57 +/- 0.79 vs. 9.57 +/- 0.38) and the urine protein/creatinine ratio (0.50 +/- 0.06 vs. 0.80 +/- 0.18). MIX also enhanced lipid profiles and renal function by improving renal tubular dilation, restoring renal structures, and reducing glomerulosclerosis, basal membrane thickening, and glycogen deposition. These effects were achieved by reducing the protein and gene expression of collagen II (Col-II), connective tissue growth factor, and collagen I (Col-I).Conclusion MIX inhibits the transforming growth factor-beta/Smads signaling pathway, thus alleviating renal fibrosis, and can be used to develop a treatment for DKD.
引用
收藏
页数:11
相关论文
共 50 条
[31]   Pathogenesis of diabetic kidney disease: Review of cellular aspects of renal lesions [J].
Sahib, Mohanad Naji ;
Abdulameer, Shaymaa Abdalwahed ;
Abd Aziz, Noorizan ;
Hassan, Yahaya .
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 3 (11) :507-514
[32]   Impact of cigarette smoking on kidney inflammation and fibrosis in diabetic rats [J].
Mayyas, Fadia ;
Alzoubi, Karem H. .
INHALATION TOXICOLOGY, 2019, 31 (02) :45-51
[33]   Ameliorative effect of ursolic acid on renal fibrosis in adenine-induced chronic kidney disease in rats [J].
Thakur, Richa ;
Sharma, Anshuk ;
Lingaraju, Madhu C. ;
Begum, Jubeda ;
Kumar, Dhirendra ;
Mathesh, Karikalan ;
Kumar, Pawan ;
Singh, Thakur Uttam ;
Kumar, Dinesh .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 :972-980
[34]   Suramin Inhibits Renal Fibrosis in Chronic Kidney Disease [J].
Liu, Na ;
Tolbert, Evelyn ;
Pang, Maoyin ;
Ponnusamy, Murugavel ;
Yan, Haidong ;
Zhuang, Shougang .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (06) :1064-1075
[35]   Chronic kidney disease growth factors in renal fibrosis [J].
Boor, Peter ;
Floege, Juergen .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (07) :391-400
[36]   Interference of periostin attenuates pathological changes, proinflammatory markers and renal fibrosis in diabetic kidney injury [J].
Duan, Xiaoting ;
Chen, Cheng ;
Liu, Xiaoli ;
Wang, Taoxia ;
Feng, Shuning ;
Li, Jianwei ;
Li, Guiying .
GENES & GENOMICS, 2023, 45 (11) :1389-1397
[37]   Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors [J].
Guo, Wenwen ;
Li, Han ;
Li, Yixuan ;
Kong, Wen .
BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
[38]   Molecular profiling of urinary extracellular vesicles in chronic kidney disease and renal fibrosis [J].
Tepus, Melanie ;
Tonoli, Elisa ;
Verderio, Elisabetta A. M. .
FRONTIERS IN PHARMACOLOGY, 2023, 13
[39]   Role of Uremic Toxins, Oxidative Stress, and Renal Fibrosis in Chronic Kidney Disease [J].
Frak, Weronika ;
Dabek, Bartlomiej ;
Balcerczyk-Lis, Marta ;
Motor, Jakub ;
Radzioch, Ewa ;
Mlynarska, Ewelina ;
Rysz, Jacek ;
Franczyk, Beata .
ANTIOXIDANTS, 2024, 13 (06)
[40]   Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease [J].
He, Jianhua ;
Xu, Yong ;
Koya, Daisuke ;
Kanasaki, Keizo .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (04) :488-497